Is Nature's Sunshine Products, Inc. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Nature's Sunshine Products, Inc. has moved from attractive to fair. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 26, which is significantly higher than the peer average of 21.11 for comparable companies. Additionally, the EV to EBITDA ratio stands at 5.08, while peers like LifeVantage Corp. have a more favorable ratio of 8.26, indicating that Nature's Sunshine may not be as efficiently valued in comparison to its industry counterparts.
In terms of performance, Nature's Sunshine has shown a YTD return of -3.27%, lagging behind the S&P 500's return of 13.30%, which further reinforces the notion of overvaluation. The company's ROCE is relatively strong at 27.36%, yet its ROE of 6.38% suggests that shareholder returns are not keeping pace with the cost of equity, adding to the overall valuation concerns.